Utilize the web fullyThanks to cookies, browsing the web will be easier and more comfortable. To process some of them, we need your consent which you can give by clicking the “Accept all” button. More information about cookies and their settings. By refusing, only essential cookies will be loaded.
Accept all Refuse
Show cookie utilization selection

UO > About > Organizational Structure > Faculties & Institutes > Faculty of Medicine > Departments & Centres > Department of Hematooncology

Ivo Demel


Academic degree, name, surname:
MUDr. Ivo Demel
Room, floor, building:
Position:
Research interests and teaching:
Department (Faculty):
Department of Haematooncology (Faculty of Medicine)
Phone number, mobile:
E-mail:



No record found.



stáž
Ivo Demel
Year: 2025
work experience abroad
 
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic
Ondrej Šušol, Barbora Šušolová, Ondřej Klempíř, Milan Navrátil, Jaromír Gumulec, Zdeněk Kořístek, Juraj Ďuraš, Michal Kaščák, Jana Fečková Mihályová, Lukáš Stejskal, Tomáš Jelínek, Petra Richterová, Lenka Szeligová, Plonkova Hana, Jana Zuchnická, Barbora Dluhošová, Ivo Demel, David Buffa, Katarína Hradská, Tereza Popková, Ludmila MUROŇOVÁ, Martin Lachnit, Klára Lančová, Roman Hájek ... other authors
Year: 2024, CANCER MEDICINE
journal article
 
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study
Ivo Demel, David Skopal, Eliska Safrankova, Petra Rozsivalova, Pavel Jindra, Jiri Sramek, Adela Turkova, Jan Vydra, Klara Labska, Jana Vedrova, Martin Cernan, Tomas Szotkowski, Heidi Mocikova, Lenka Hynkova, Ondrej Šušol, Ingrid Kovacova, David Belada, Roman Hájek ... other authors
Year: 2023, ANNALS OF HEMATOLOGY
journal article
 
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients – A Czech multicenter experience
Barbora Weinbergerova, Ivo Demel, Benjamin Visek, Jan Valka, Martin Cernan, Pavel Jindra, Jan Novak, Lukas Stejskal, Flora Kovacsova, Tomas Kabut, Tomas Szotkowski, Roman Hájek, Pavel Zak, Petr Cetkovsky, Zdenek Kral, Jiri Mayer ... other authors
Year: 2022, Hematological Oncology
journal article
 

No record found.

View more records

View more records

View more records

View more records

View more records

View more records

View more records

View more records



No record found.



No record found.



Increasing the safety of high-risk patients with immune thrombocytopenia by means of home blood count monitoring
Period
1/2024 – 12/2024
Provider
Specifický VŠ výzkum
State
finished
Role in the project
Co-Investigator
Total costs
112 200 CZK
 

Instagram
RSS
social hub